Funding round
LifeMine Series E
LifeMine, which works in top-down drug discovery services in Cambridge, raised $263M in a Series E round announced on 7 Aug 2026, led by Milky Way Investments. 9 firms took part. It is LifeMine's sixth venture round on record; the one before was a Series D in Aug 2026.
$263M
Amount raised
Not disclosed
Post-money valuation
9
Investors
1 lead
Valuation
What this round says about the price
LifeMine did not disclose a valuation in this round. It is 42% of the $623M LifeMine has raised in the venture rounds on record. No later venture round is on record for LifeMine.
LifeMine's funding rounds
LifeMine has 6 venture rounds on record. This one is highlighted.
- Seed 12 Jan 2016, led by WuXi Healthcare Ventures $5.0M
- Series A 18 Sep 2017, led by WuXi Healthcare Ventures $55M
- Series B 8 Jan 2021, led by Milky Way Investments $50M
- Series C 23 Mar 2022, led by Fidelity Management & Research Company $175M
- Series D 6 Aug 2026, led by Milky Way Investments $75M
- Series E this round 7 Aug 2026, led by Milky Way Investments $263M
Investors
Who put money in
Milky Way Investments led the round with 8 other firms.
Lead investor
- Milky Way Investments new investor
Also in the round
- Bezos Expeditions new investor
- Gates Frontier new investor
- backs 109 venture-backed companies new investor
- GV backs 428 venture-backed companies new investor
- LoLa Capital Partners new investor
- GlaxoSmithKline (GSK) new investor
- Invus backs 83 venture-backed companies new investor
- ARCH Venture Partners backs 99 venture-backed companies new investor
Use of proceeds
What the money is for
According to the announcement, the money goes to product development.
- Product development
Comparable rounds
How it compares
5 Series E rounds in Biotechnology within a year either side disclosed an amount; the median was $50M, and this round was 5.3 times the median. The closest in time, other companies' Series E rounds in Biotechnology:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Biotechnology | 25 Aug 2026 | $50M | not disclosed | not named |
| Enveda Biotechnology | 23 Sep 2026 | $311M | $2.00B | Catalio Capital Management |
| Element Biosciences Biotechnology | 9 Jun 2026 | $175M | not disclosed | Samsung Electronics |
| Biotechnology | 15 Apr 2026 | $40M | $1.00B | not named |
| Biotechnology | 8 Jan 2026 | $48M | not disclosed | ARCH Venture Partners and M Ventures |
Sources
Where this comes from
Reported by 4 sources.
Questions
Frequently asked
How much did LifeMine raise in its Series E round?
LifeMine raised $263M in its Series E round, announced in Aug 2026.
Who led LifeMine's Series E round?
Milky Way Investments led it, with Bezos Expeditions, Gates Frontier, RA Capital, GV and LoLa Capital Partners and 3 more.
What was LifeMine's valuation at the Series E round?
It was not disclosed.
How does it compare with other Series E rounds in Biotechnology?
5 Series E rounds in Biotechnology within a year either side disclosed an amount; the median was $50M, and this round was 5.3 times the median.